NCT07196943 Prospective Outcomes of Guided Equator Overdentures
| NCT ID | NCT07196943 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Menoufia University |
| Condition | Bone Loss |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-09-01 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective clinical study evaluated the 3-year performance of mandibular implant-supported overdentures (IODs) placed using a fully guided static computer-assisted implant surgery (CAIS) protocol. Primary outcomes included implant survival, peri-implant soft tissue health, and marginal bone loss. Findings provide evidence for the predictability of digital surgical workflows in removable prosthodontics.
Eligibility Criteria
* Inclusion Criteria: * Completely edentulous mandible requiring implant-supported overdenture rehabilitation * Adequate bone volume to accommodate four implants in a quadrilateral configuration, confirmed by cone-beam computed tomography (CBCT) * Age between 40 and 75 years * Good general health with no systemic contraindications to implant surgery * Willingness and ability to provide informed consent * Commitment to attend all scheduled follow-up visits over the 3-year study period * Exclusion Criteria: * Uncontrolled systemic diseases (e.g., diabetes mellitus, osteoporosis) * History of radiotherapy in the head and neck region * Untreated oral infections or severe periodontal disease * Poor oral hygiene or inability to comply with maintenance protocols * Heavy smoking (\>10 cigarettes/day) or alcohol abuse * Known allergy or intolerance to materials or medications used in the study
Contact & Investigator
Mohammed El-Sawy, PhD
PRINCIPAL INVESTIGATOR
Menoufia University
Frequently Asked Questions
Who can join the NCT07196943 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Bone Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07196943 currently recruiting?
Yes, NCT07196943 is actively recruiting participants. Contact the research team at Dr_sawy@windowslive.com for enrollment information.
Where is the NCT07196943 trial being conducted?
This trial is being conducted at Shibīn al Kawm, Egypt.
Who is sponsoring the NCT07196943 clinical trial?
NCT07196943 is sponsored by Menoufia University. The principal investigator is Mohammed El-Sawy, PhD at Menoufia University. The trial plans to enroll 40 participants.